Glaucoma

Visus Therapeutics has entered into worldwide exclusive licensing agreements with Cella Therapeutics and DelSiTech, according to a press release.

Individuals with a high polygenic risk for glaucoma have similar likelihood to develop the disease as those with the most common single-gene pathogenic variant and at an equivalent age, according to a study.

Quality of life for children with allergic conjunctivitis was significantly lower for them and their parents compared with children without it, according to findings published in JAMA Ophthalmology.

LAS VEGAS — Patients with glaucoma showed high response rates after receiving a bimatoprost implant to reduce IOP, according to research presented at the American Society of Cataract and Refractive Surgery meeting.

LAS VEGAS — Automated direct selective laser trabeculoplasty appears to reduce IOP in patients with primary open-angle glaucoma, according to a speaker here.

LAS VEGAS — Effective strategies to treat hypotony in patients with prior trabeculectomy who are undergoing cataract surgery vary depending on severity, according to a speaker here.

LAS VEGAS —Finding treatment options for glaucoma beyond IOP lowering may be the future course toward preventing blindness in glaucoma, according to a speaker here.

The CATS-D disposable prism, a tip replacement for the Goldmann tonometer, has been cleared by the FDA, according to a press release from CATS Tonometer.

Patients with and without glaucoma who underwent Nd:YAG capsulotomy had no immediate significant IOP change and no retinal tears or detachments after 1 week, according to a poster presented at Cataract Surgery: Telling It Like It Is.

IOP fluctuated by season in patients with healthy eyes and primary open-angle glaucoma, with an increase in the winter and decrease in the summer, according to a study published in Ophthalmology Glaucoma.